Cargando…
Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiation
BACKGROUND: The epidermal growth factor receptor (EGFR) is an important regulator of cell growth and survival, and is highly variable in tumor cells. The most prevalent variation of the EGFR extracellular domain is the EGFR variant III (EGFRvIII). Some studies imply that EGFRvIII may be responsible...
Autores principales: | Koch, Dominik Thomas, Pickhard, Anja, Gebel, Lena, Buchberger, Anna Maria S., Bas, Murat, Mogler, Carolin, Reiter, Rudolf, Piontek, Guido, Wirth, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464818/ https://www.ncbi.nlm.nih.gov/pubmed/28427242 http://dx.doi.org/10.18632/oncotarget.15949 |
Ejemplares similares
-
The Aurora-Kinase A Phe31-Ile polymorphism as possible predictor of response to treatment in head and neck squamous cell carcinoma
por: Baumann, Alexander, et al.
Publicado: (2018) -
Bradykinin Receptor B1 and C-Reactive Protein as Prognostic Factors for Pharyngocutaneous Fistula Development After Laryngectomy
por: Koob, Isabelle, et al.
Publicado: (2019) -
The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphism
por: Pickhard, Anja, et al.
Publicado: (2014) -
Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways
por: Pickhard, Anja C, et al.
Publicado: (2011) -
High NOTCH1 mRNA Expression Is Associated with Better Survival in HNSCC
por: Wirth, Markus, et al.
Publicado: (2018)